Microbial metabolite trimethylamine-N-oxide facilitates colorectal inflammation-cancer transformation by blocking lysosomal degradation of Wnt signaling. [PDF]
Yang K +5 more
europepmc +1 more source
Utility of trimethylamine N-oxide (TMAO) as a biomarker for risk stratification in chronic kidney disease: a multicenter observational study. [PDF]
Lei Y +14 more
europepmc +1 more source
Monooxygenase-dehydrogenase cascade for sustained enzymatic remediation of TMA in salmon protein hydrolysates. [PDF]
Ree R +7 more
europepmc +1 more source
Trimethylamine N-Oxide Linking Gut Microbiota to Cardiocerebral Disease Is a Novel Biomarker for Stroke Subtypes With Mixed Etiology: A Prospective Cohort Study. [PDF]
Wang Y +9 more
europepmc +1 more source
Diabetic cardiomyopathy from a gut microbiota perspective: research progress and prospects. [PDF]
Liang Y, Gao Y, Wang W, Zhao Z.
europepmc +1 more source
Targeting gut-liver-kidney axis: microbiota-derived metabolites and therapeutic implications. [PDF]
Zhang Y +6 more
europepmc +1 more source
Gut microbiota-derived metabolites as immune modulators in aging and age-related chronic inflammatory diseases. [PDF]
Chen N +7 more
europepmc +1 more source
Targeting FMO3 suppresses the malignant phenotype of colorectal cancer: evidence from bioinformatics to functional experiments. [PDF]
Su R +7 more
europepmc +1 more source
Dietary Fatty Acids Modulate Gut Microbiota-Derived Trimethylamine-N-Oxide: Potential Mechanisms and Future Perspective. [PDF]
Kilic E, Basaran P.
europepmc +1 more source

